LAURA TROIDLE: Open Payments
NPI 1548256282 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,114 in 94 payments from 21 companies in 2025. Trend: 2023 $1,234 · 2024 $1,636 · 2025 $2,114
Food & beverage: $2,105Education: $8
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $232 |
| Travere Therapeutics, Inc. | 13 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $192 |
| AstraZeneca Pharmaceuticals LP | 9 | $182 |
| AKEBIA THERAPEUTICS INC | 6 | $167 |
| Amgen Inc. | 6 | $139 |
| Mallinckrodt Hospital Products Inc. | 6 | $131 |
| Calliditas Therapeutics US Inc. | 4 | $127 |
| Fresenius USA Marketing, Inc. | 5 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $108 |
Products named: JARDIANCE, Ozempic, Vafseo, FARXIGA, ACTHAR, TARPEYO, VELPHORO, KRYSTEXXA.
Industry payments across CT — which companies pay providers there.
